Please login to the form below

Not currently logged in
Email:
Password:

Premier Research appoints Dr Colin Hayward as European medical director

He will lead the company's European medical affairs and pharmacovigilance operations

US pharma services company Premier Research has appointed Dr Colin Hayward to lead and develop its European medical affairs and pharmacovigilance operations.

He joins the Philadelphia-headquartered firm as European medical director from pharmaceutical medicine consultancy Prism Ideas where he served as director.

Prior to that role, Dr Hayward served at Roche, where he held a series of positions in pharmacovigilance leading up to that of international medical leader. Before that he worked in the UK's NHS in anaesthesia and intensive care.

"Dr Hayward brings medical expertise, clinical knowledge, leadership, and a wealth of experience in key areas important to our customers and will provide an added level of therapeutic insight to Premier's services," said Sue Stansfield, executive vice president, clinical development.

"He will be a tremendous asset for both employees and customers and is a welcome addition to our strong team in Europe."

Stansfield herself also joined Premier Research in January, and in her new role will have global responsibility for leading the company's clinical trial management services.

She has more than 25 years experience in the pharmaceutical and contract research industries, including stints at clinical service organisations PRA, PPD and Quintiles.

25th January 2012

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
bmore group

OUR PROMISE: BETTER HEALTH FROM TRIAL TO TREATMENT.We are a full service, independent network of specialist agencies under one roof....

Latest intelligence

The search for treatments for Parkinson’s disease
The research requires resilience but pharma is urged to ‘keep innovating, keep trying’...
Margot Hannah, OPEN Health - A personal perspective of LGBT+ and diversity.
Ditch the Label – it’s just me....
The impact of COVID-19 on clinical trials
As all industry sectors work to assess both the impact and the optimal path forward, the effects are expected to be diverse and long-lasting...

Infographics